| 18F-FDG PET and CT scans detect new imaging patterns of response and progression in patients with Hodgkin lymphoma treated by anti–programmed death 1 immune checkpoint inhibitor L Dercle, RD Seban, J Lazarovici, LH Schwartz, R Houot, S Ammari, ... Journal of Nuclear Medicine 59 (1), 15-24, 2018 | 121 | 2018 |
| Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors RD Seban, L Mezquita, A Berenbaum, L Dercle, A Botticella, ... European journal of nuclear medicine and molecular imaging 47, 1147-1157, 2020 | 116 | 2020 |
| Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics RD Seban, JS Nemer, A Marabelle, R Yeh, E Deutsch, S Ammari, ... European journal of nuclear medicine and molecular imaging 46, 2298-2310, 2019 | 108 | 2019 |
| Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy L Dercle, S Ammari, S Champiat, C Massard, C Ferté, L Taihi, RD Seban, ... European journal of cancer 65, 33-42, 2016 | 64 | 2016 |
| Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in … E Lopci, RJ Hicks, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, ... European journal of nuclear medicine and molecular imaging 49 (7), 2323-2341, 2022 | 63 | 2022 |
| Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4 RD Seban, A Moya-Plana, L Antonios, R Yeh, A Marabelle, E Deutsch, ... European journal of nuclear medicine and molecular imaging 47, 2301-2312, 2020 | 55 | 2020 |
| Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging A Peltier, RD Seban, I Buvat, FC Bidard, F Mechta-Grigoriou Seminars in Cancer Biology 86, 262-272, 2022 | 42 | 2022 |
| Early 18F-FDG PET/CT response predicts survival in relapsed or refractory Hodgkin lymphoma treated with nivolumab A Chen, FZ Mokrane, LH Schwartz, F Morschhauser, A Stamatoullas, ... Journal of Nuclear Medicine 61 (5), 649-654, 2020 | 42 | 2020 |
| Association of the metabolic score using baseline FDG-PET/CT and dNLR with immunotherapy outcomes in advanced NSCLC patients treated with first-line pembrolizumab RD Seban, JB Assié, E Giroux-Leprieur, MA Massiani, M Soussan, ... Cancers 12 (8), 2234, 2020 | 36 | 2020 |
| Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma FZ Mokrane, A Chen, LH Schwartz, F Morschhauser, A Stamatoullas, ... Radiology 295 (3), 651-661, 2020 | 34 | 2020 |
| Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma L Dercle, S Ammari, RD Seban, LH Schwartz, R Houot, N Labaied, ... European Journal of Cancer 91, 136-144, 2018 | 33 | 2018 |
| Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo-or immunotherapy RD Seban, JB Assié, E Giroux-Leprieur, MA Massiani, G Bonardel, ... Lung Cancer 159, 45-55, 2021 | 30 | 2021 |
| FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer RD Seban, JB Assie, E Giroux-Leprieur, MA Massiani, M Soussan, ... Annals of Nuclear Medicine 34, 968-974, 2020 | 29 | 2020 |
| Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies L Dercle, D Hartl, L Rozenblum-Beddok, FZ Mokrane, RD Seban, R Yeh, ... European Radiology 28, 1761-1770, 2018 | 26 | 2018 |
| Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer L Groussin, H Theodon, L Bessiene, L Bricaire, F Bonnet-Serrano, ... Thyroid 32 (5), 594-598, 2022 | 23 | 2022 |
| Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study C Cabanié, S Ammari, S Hans, C Pobel, A Laparra, FX Danlos, ... European Journal of Cancer 156, 46-59, 2021 | 21 | 2021 |
| Emerging and evolving concepts in cancer immunotherapy imaging L Dercle, S Sun, RD Seban, A Mekki, R Sun, L Tselikas, S Hans, ... Radiology 306 (1), 32-46, 2023 | 19 | 2023 |
| Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer RD Seban, R Rouzier, A Latouche, N Deleval, JM Guinebretiere, I Buvat, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 3560-3570, 2021 | 18 | 2021 |
| Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy RD Seban, C Robert, L Dercle, R Yeh, A Dunant, S Reuze, A Schernberg, ... Oncoimmunology 8 (5), e1574197, 2019 | 17 | 2019 |
| Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients RD Seban, L Champion, LH Schwartz, L Dercle European Journal of Nuclear Medicine and Molecular Imaging 48, 2309-2311, 2021 | 14 | 2021 |
